# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-18-014676
Filing Date
2018-10-30
Accepted
2018-10-30 17:05:45
Documents
4
Period of Report
2018-11-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRELIMINARY PROXY STATEMENT | pre14a1018_actiniumpharma.htm | PRE 14A | 413771
2 | GRAPHIC | image_001.jpg | GRAPHIC | 25910
3 | GRAPHIC | proxy1.jpg | GRAPHIC | 204815
4 | GRAPHIC | proxy2.jpg | GRAPHIC | 255554
| Complete submission text file | 0001213900-18-014676.txt |  | 1084845

Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36374 | Film No.: 181147725
SIC: 2834 Pharmaceutical Preparations